D. Waag

发表

Injection of Inactivated Phase I Coxiella burnetii Increases Non‐specific Resistance to Infection and Stimulates Lymphokine Production in Mice

J. Williams, D. Waag, M. Kende, 1990, Annals of the New York Academy of Sciences.

Evaluation of cynomolgus (Macaca fascicularis) and rhesus (Macaca mulatta) monkeys as experimental models of acute Q fever after aerosol exposure to phase-I Coxiella burnetii.

D. Waag, J. Estep, M. Pitt, 1999, Laboratory animal science.

The Hamster Model of Intraperitoneal Burkholderia mallei (Glanders)

D. Waag, D. Brown, D. Fritz, 1999, Veterinary pathology.

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques.

B. Ivins, D. Waag, A. Friedlander, 1996, Vaccine.

Application of carbohydrate microarray technology for the detection of Burkholderia pseudomallei, Bacillus anthracis and Francisella tularensis antibodies.

S. Welkos, D. DeShazer, S. Peacock, 2008, Carbohydrate research.

Humoral Immune Responses in a Human Case of Glanders

D. DeShazer, D. Waag, M. England, 2012, Clinical and Vaccine Immunology.

Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies

D. DeShazer, D. Waag, N. Parthasarathy, 2006, Diagnostic Microbiology and Infectious Disease.

Transdiaphragmatic lymphatic transport of intraperitoneally administered marker in hamsters.

D. Waag, D. Fritz, 1999, Laboratory animal science.

Evaluation ofSpecificity ofIndirect Enzyme-Linked Immunosorbent AssayforDiagnosis ofHumanQ Fever

J. Olson, D. Waag, I. Uhaa, 1994 .

Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model

Jennifer L. Dankmeyer, C. Klimko, P. Worsham, 2021, PLoS neglected tropical diseases.

Suppression of in vitro lymphocyte proliferation in C57BL/10 ScN mice vaccinated with phase I Coxiella burnetii

J. Williams, D. Waag, T. Damrow, 1985, Infection and immunity.

The Type IV Pilin of Burkholderia mallei Is Highly Immunogenic but Fails To Protect against Lethal Aerosol Challenge in a Murine Model

D. Waag, M. Donnenberg, Q. Guo, 2007, Infection and Immunity.

Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever

J. Williams, D. Waag, L. Fries, 1993, Infection and immunity.

Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice

J. Williams, D. Waag, T. Damrow, 1986, Infection and immunity.

Vaccines against Coxiellosis and Q Fever Development of a Chloroform:Methanol Residue Subunit of Phase I Coxiella burnetii for the Immunization of Animals

J. Williams, D. Waag, M. Peacock, 1992, Annals of the New York Academy of Sciences.

Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders

S. Cassidy, J. Goldberg, D. Waag, 2015, PloS one.

Coxiella burnetii: host and bacterial responses to infection.

D. Waag, 2007, Vaccine.

Chapter 10 Q Fever Introduction History Military Relevance Infectious Agent Disinfection Pasteurization Irradiation Disease Epidemiology Pathogenesis Infection (coxiellosis) in Animals Clinical Disease in Humans Diagnosis Serology Culture Treatment Prophylaxis Summary

D. Waag, 2008 .

Validation of an enzyme immunoassay for serodiagnosis of acute Q fever

J. Williams, D. Waag, T. Marrie, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.

D. Waag, M. Pitt, W. Byrne, 2002, Vaccine.

Prevalence of Coxiella burnetii infections among North Dakota sheep producers.

H. R. Guo, D. Waag, L. Shireley, 1998, Journal of occupational and environmental medicine.

Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.

D. Waag, M. Pitt, M. England, 1997, Vaccine.

Q fever: from deer to dog to man

D. Waag, T. Marrie, Thomas Laughlin, 1991, The Lancet.

Immune modulation by Coxiella burnetii: characterization of a phase I immunosuppressive complex differentially expressed among strains.

J. Williams, D. Waag, 1988, Immunopharmacology and immunotoxicology.

Exposure to parturient cats: a risk factor for acquisition of Q fever in Maritime Canada.

J. Williams, E. Mintz, D. Waag, 1988, The Journal of infectious diseases.

Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia 1 mallei strains isolated from infected mice

S. Welkos, C. Klimko, C. Cote, 2017 .

Dysregulation of TNF-α and IFN-γ expression is a common host immune response in a chronically infected mouse model of melioidosis when comparing multiple human strains of Burkholderia pseudomallei

Jennifer L. Dankmeyer, S. Welkos, P. Worsham, 2020, BMC Immunology.

Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice

S. Welkos, C. Klimko, P. Worsham, 2016, Archives of Microbiology.

Distinct human antibody response to the biological warfare agent Burkholderia mallei

J. Goldberg, D. DeShazer, D. Waag, 2012, Virulence.

In Vitro Antibiotic Susceptibilities ofBurkholderia mallei (Causative Agent of Glanders) Determined by Broth Microdilution and E-Test

D. Waag, W. Byrne, H. Heine, 2001, Antimicrobial Agents and Chemotherapy.

Characterization of cellular immune response and innate immune signaling in human and nonhuman primate primary mononuclear cells exposed to Burkholderia mallei.

D. Waag, R. Ulrich, K. Amemiya, 2015, Microbial pathogenesis.

Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice.

R. Ulrich, D. DeShazer, D. Waag, 2005, Vaccine.

CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols

D. Waag, H. C. Gelhaus, Mark Smith, 2010, Journal of immune based therapies and vaccines.

Application of Polysaccharide Microarray Technology for the Serodiagnosis of Burkholderia pseudomallei Infection (Melioidosis) in Humans

D. DeShazer, S. Peacock, D. Waag, 2008 .

Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies.

D. DeShazer, D. Waag, N. Parthasarathy, 2008, Diagnostic microbiology and infectious disease.

Mouse Model of Sublethal and Lethal Intraperitoneal Glanders (Burkholderia mallei)

D. DeShazer, D. Waag, D. Brown, 2000, Veterinary pathology.

Structure‐Based Design and Synthesis of a Small Molecule that Exhibits Anti‐inflammatory Activity by Inhibition of MyD88‐mediated Signaling to Bacterial Toxin Exposure

J. Rebek, D. Waag, Sacha Javor, 2015, Chemical biology & drug design.

Characterization of the non-specific humoral and cellular antiviral immunity stimulated by the chloroform-methanol residue (CMR) fraction of Coxiella burnetii.

J. Williams, D. Waag, M. Kende, 1995, Antiviral research.

Efficacy of Coxiella burnetii and its chloroform-methanol residue (CMR) fraction against Rift Valley fever virus infection in mice.

J. Williams, D. Waag, M. Kende, 1995, Antiviral research.

Poker players' pneumonia. An urban outbreak of Q fever following exposure to a parturient cat.

J. Williams, D. Waag, T. Marrie, 1988, The New England journal of medicine.

Efficacy of Postexposure Therapy against Glanders in Mice

D. Waag, 2015, Antimicrobial Agents and Chemotherapy.

Burkholderia mallei tssM Encodes a Putative Deubiquitinase That Is Secreted and Expressed inside Infected RAW 264.7 Murine Macrophages

M. Schell, D. DeShazer, K. Wilkinson, 2009, Infection and Immunity.

Activation of Toll-Like Receptors by Live Gram-Negative Bacterial Pathogens Reveals Mitigation of TLR4 Responses and Activation of TLR5 by Flagella

Jennifer L. Dankmeyer, D. DeShazer, P. Worsham, 2021, Frontiers in Cellular and Infection Microbiology.

Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei.

Jennifer L. Dankmeyer, S. Kern, S. Welkos, 2021, Microbial pathogenesis.

Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays

S. Kern, S. Welkos, C. Klimko, 2015, PloS one.

Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.

D. DeShazer, D. Waag, D. Woods, 2001, Microbial pathogenesis.

Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei

Jennifer L. Dankmeyer, S. Kern, S. Welkos, 2018, PloS one.

Proteomic Analysis of Non-human Primate Peripheral Blood Mononuclear Cells During Burkholderia mallei Infection Reveals a Role of Ezrin in Glanders Pathogenesis

Yingyao Zhou, Chih-yuan Chiang, M. Ward, 2021, Frontiers in Microbiology.

Real-time PCR for the early detection and quantification of Coxiella burnetii as an alternative to the murine bioassay.

D. Norwood, D. Waag, D. Kulesh, 2009, Molecular and cellular probes.

Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis

J. Williams, D. Waag, G. Sandstrom, 1995, Clinical and Diagnostic Laboratory Immunology.

Low-Dose Priming before Vaccination with the Phase I Chloroform-Methanol Residue Vaccine against Q Fever Enhances Humoral and Cellular Immune Responses to Coxiella burnetii

D. Waag, M. England, C. Bolt, 2008, Clinical and Vaccine Immunology.

Immunogenicity of a new lot of Francisella tularensis live vaccine strain in human volunteers.

J. Williams, G. Sandström, D. Waag, 1996, FEMS immunology and medical microbiology.

Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis

J. Williams, D. Waag, G. Sandstrom, 1992, Journal of clinical microbiology.

Evaluation of specificity of indirect enzyme-linked immunosorbent assay for diagnosis of human Q fever

J. Williams, J. Olson, D. Waag, 1994, Journal of clinical microbiology.

Mouse models of aerosol-acquired tularemia caused by Francisella tularensis types A and B.

D. Waag, D. Fritz, L. Miller, 2014, Comparative medicine.

Chapter 8 GLANDERS

B. C. Gregory, D. Waag, M. Burtnick, 2018 .

Chapter 6 GLANDERS BRIDGET

D. Waag, C. Gregory, 2008 .

Pathogenesis of and Immunity to Coxiella burnetii

H. A. Thompson, D. Waag, 2005 .

Laser Scanning Confocal Microscopy Was Used to Validate the Presence of Burkholderia pseudomallei or B. mallei in Formalin-Fixed Paraffin Embedded Tissues

Jennifer L. Dankmeyer, S. Welkos, P. Worsham, 2020, Tropical medicine and infectious disease.

Comparison of experimental respiratory tularemia in three nonhuman primate species.

D. Waag, D. Alves, A. Glynn, 2015, Comparative immunology, microbiology and infectious diseases.

Biodefense-Driven Murine Model of Pneumonic Melioidosis

J. Jeddeloh, D. Waag, J. Hartings, 2003, Infection and Immunity.

A refined guinea pig model for evaluating delayed-type hypersensitivity reactions caused by Q fever vaccines.

D. Waag, D. Ruble, G. Jaax, 1994, Laboratory animal science.

Nonviable Burkholderia mallei Induces a Mixed Th1- and Th2-Like Cytokine Response in BALB/c Mice

D. DeShazer, D. Waag, K. Amemiya, 2002, Infection and Immunity.

Detection of the host immune response to Burkholderia mallei heat-shock proteins GroEL and DnaK in a glanders patient and infected mice.

D. DeShazer, D. Waag, W. Ribot, 2007, Diagnostic microbiology and infectious disease.

Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice.

D. Waag, T. Chanh, K. Amemiya, 2006, Vaccine.

Antigenic Structure of Coxiella burnetii

T. Hoover, J. Williams, D. Waag, 1990, Annals of the New York Academy of Sciences.

The Efficacy of Post-Exposure Therapy Against Glanders in Mice 1 2

D. Waag, 2015 .

A CpG Oligonucleotide Can Protect Mice from a Low Aerosol Challenge Dose of Burkholderia mallei

D. Waag, A. Krieg, M. McCluskie, 2006, Infection and Immunity.

CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei , Infection and Immunity

D. Waag, A. Krieg, M. McCluskie, 2006 .

Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.

D. Waag, C. Wilhelmsen, 2000, Comparative medicine.

Monoclonal Antibodies Passively Protect BALB/c Mice against Burkholderia mallei Aerosol Challenge

D. Waag, T. Chanh, P. Gibbs, 2006, Infection and Immunity.